...
首页> 外文期刊>Oncology letters >Chemoradiotherapy alone vs. chemoradiotherapy and hysterectomy for locally advanced cervical cancer: A systematic review and updated meta-analysis
【24h】

Chemoradiotherapy alone vs. chemoradiotherapy and hysterectomy for locally advanced cervical cancer: A systematic review and updated meta-analysis

机译:EnhomorAdiotherapy单独疗法对局部晚期宫颈癌的化学疗法和子宫切除术:系统评价和更新的荟萃分析

获取原文
获取原文并翻译 | 示例

摘要

The benefit of adjuvant hysterectomy after definitive concurrent chemoradiotherapy (CCRT) for locally-advanced cervical cancer (LACC) is controversial. The purpose of the present study was to systematically search the literature and perform a meta-analysis to compare overall survival (OS) and disease-free survival (DFS) between patients subjected to CCRT with hysterectomy and those who underwent CCRT alone. The PubMed, Scopus, Embase and Google scholar databases were searched. A meta-analysis to determine hazard ratios (HRs) and odds ratios (ORs) with meta-regression was performed for the following moderators: Disease stage, histology and proportion of radical hysterectomy. Data from 14 studies were included. The results indicated that patients who received CCRT with hysterectomy had significantly better OS (HR, 0.72; 95% CI, 0.56 to 0.91; I-2=19%; P=0.007) and DFS (HR, 0.72; 95% CI, 0.56 to 0.93; I-2=27%; P=0.01) than those treated with CCRT alone. However, in a subgroup analysis by study type, the results were significant only for retrospective studies but not for randomized controlled trials (RCTs). However, only 2 RCTs were included with small sample size, heterogeneity and low overall quality. Subgroup analyses based on the use of brachytherapy in the CCRT with hysterectomy group demonstrated no difference in OS and DFS between the two groups. Regarding the absolute numbers of death and recurrence events, no significant difference in mortality (OR, 0.91; 95% CI, 0.62 to 1.33; I-2=0%; P=0.64) was determined between the two groups, but a significantly reduced incidence of recurrence was observed in the CCRT with hysterectomy group (OR, 0.61; 95% CI, 0.47-0.79; I-2=29%; P=0.0002). The meta-regression results point to a significant influence of the proportion of stage II patients on OS. Despite the overall analysis indicating improved OS and DFS with the use of adjuvant hysterectomy after CCRT, subgroup analysis based on similar treatment protocols failed to demonstrate any significant benefit of hysterectomy in LACC. However, the results indicated that the recurrence rate may be higher in patients undergoing CCRT without hysterectomy. The limited quality of the studies included and selection bias from retrospective studies restrict the possibility to draw strong conclusions.
机译:局部晚期宫颈癌(LACC)行确定性同步放化疗(CCRT)后辅助子宫切除术的益处存在争议。本研究的目的是系统地检索文献并进行荟萃分析,以比较接受CCRT并子宫切除术的患者和单独接受CCRT的患者的总生存率(OS)和无病生存率(DFS)。搜索了PubMed、Scopus、Embase和谷歌学者数据库。对以下调节因素进行荟萃分析,以确定风险比(HRs)和优势比(ORs),并进行荟萃回归分析:疾病分期、组织学和根治性子宫切除术的比例。包括14项研究的数据。结果表明,接受CCRT子宫切除术的患者的OS(HR,0.72;95%CI,0.56至0.91;I-2=19%;P=0.007)和DFS(HR,0.72;95%CI,0.56至0.93;I-2=27%;P=0.01)明显优于单独接受CCRT的患者。然而,在按研究类型进行的亚组分析中,结果仅对回顾性研究有意义,而对随机对照试验(RCT)无意义。然而,只有2个随机对照试验被纳入,样本量小,异质性和整体质量低。基于CCRT加子宫切除组近距离放疗的亚组分析显示,两组的OS和DFS无差异。关于死亡和复发事件的绝对数量,两组之间的死亡率(OR,0.91;95%CI,0.62至1.33;I-2=0%;P=0.64)没有显著差异,但在CCRT加子宫切除组中观察到复发率显著降低(OR,0.61;95%CI,0.47-0.79;I-2=29%;P=0.0002)。荟萃回归结果表明II期患者的比例对OS有显著影响。尽管总体分析表明CCRT后辅助性子宫切除术改善了OS和DFS,但基于类似治疗方案的亚组分析未能证明LACC子宫切除术有任何显著益处。然而,结果表明,接受CCRT但未行子宫切除术的患者复发率可能更高。所包含研究的有限质量和回顾性研究的选择偏差限制了得出强有力结论的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号